Identification of predictive biomarkers of overall survival (OS) in patients (pts) with advanced renal cell carcinoma (RCC) treated with interferon alpha (I) with or without bevacizumab (B): Results from CALGB 90206 (Alliance)
- Citation:
- J Clin Oncol vol 31 (15 suppl) abstr 4520
- Meeting Instance:
- ASCO 2013
- Year:
- 2013
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3615
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- A. B. Nixon S. Halabi I. Shterev M. D. Starr J. C. Brady J. P. Dutcher J. O. Hopkins H. I. Hurwitz E. Small B. Rini P. G. Febbo D. George
- Networks:
- Study
- Alliance-90206
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- Keywords: